Literature DB >> 16009097

[Discussion of relationship between quality of life and clinical effect assessment of malignant tumor treated with traditional Chinese medicine].

Hua-Fa Que1, Hong-Feng Chen, Jie-Nan Xu, Sheng Liu, De-Ming Lu, Han-Jun Tang.   

Abstract

Traditional Chinese Medicine (TCM) therapy is effective in treating malignant tumor. TCM therapy is a multi-way, multi-layer and multi-target integrated treatment characterized by "survival with tumor" and improvement of life quality. An ideal result of the TCM therapy for cancer should be a positive response of the patient with satisfactory quality of life (QOL) and longer survival time. So it is necessary to introduce the QOL, quantification of symptoms and signs and standardization of TCM syndromes to the objective, quantitative and standardized effect assessment of TCM therapy for cancer. A criterion for evaluating the effect of TCM therapy on tumors should be established, which reflects the characteristics and advantages of the TCM therapy, and meets the requirement of the developing effect assessment of modern medicine in cancer treatment. It is suggested that the treatment effect should be the sum of quality adjusted life years (QALYs) (equal to QOL multiplied by time of survival), syndrome remission rate and tumor remission rate. But the proportion of each of the three is variable, which has close relationships with the different tumor stages and corresponding treatments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009097     DOI: 10.3736/jcim20050401

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN: 1672-1977


  3 in total

1.  Therapeutic effect of Jinlongshe Granule () on quality of life of stage IV gastric cancer patients using EORTC QLQ-C30: A double-blind placebo-controlled clinical trial.

Authors:  Da-zhi Sun; Jian-peng Jiao; Xuan Zhang; Jing-yu Xu; Min Ye; Li-juan Xiu; Ying Zhao; Ye Lu; Xuan Liu; Jing Zhao; Jun Shi; Zhi-feng Qin; Pin-kang Wei
Journal:  Chin J Integr Med       Date:  2014-11-16       Impact factor: 1.978

2.  Health-related quality of life evaluated by tumor node metastasis staging system in patients with hepatocellular carcinoma.

Authors:  Cui-Xia Qiao; Xiao-Feng Zhai; Chang-Quan Ling; Qing-Bo Lang; Hui-Juan Dong; Qun Liu; Mou-Duo Li
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 3.  Establishing Chinese medicine characteristic tumor response evaluation system is the key to promote internationalization of Chinese medicine oncology.

Authors:  Jie Li; Lei Li; Rui Liu; Hong-sheng Lin
Journal:  Chin J Integr Med       Date:  2012-09-11       Impact factor: 1.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.